Arthritis Research Canada | Leading Research. Finding Answers. Saving Lives.

ROAR 2018 Public Forum

Find out about the latest in arthritis prevention and treatments on September 29th!
Register Today

September is Arthritis Awareness Month

Help us make arthritis visible by participating in our month-long campaign. Because when something is visible, we can’t ignore it.
Read More

The Arthritis Newsletter: Fall 2018

Keeping you informed about advances in arthritis research and related stories.
Read More

2017-2018 Annual Report

Want to find out what we’ve been up to over the past year? Our 2017-2018 annual report is now available online.
Read More

Follow Us on Social Media



Arthritis Research Canada’s scientific director, Dr. John Esdaile, talks to Global BC’s Coleen Christie about arthritis, who it affects, treatments, prevention and more on “Ask An Expert.”


Check out the latest news, newsletters and stories

Ways To Support

One-time gifts, Monthly giving, Gifts of Securities and more.


Informative discussions with patients, doctors and researchers.


Biologic drugs for spondyloarthritis patients: do policies in different countries affect costs and health?

Principal Investigator: Stephanie Harvard, University of British Columbia School of Population and Public Health PhD student and Arthritis Research Canada Trainee supervised by Dr. Bruno Fautrel, Pierre and Marie Curie University, Paris, and Dr. Aslam Anis, University of British Columbia School of Population and Public Health

Using information from DESIR, researchers looked at which patients satisfied the criteria to receive biologic drugs in different countries: France, Canada, Germany, the United Kingdom and Hong Kong.

read more


John Esdaile

John Esdaile

Scientific Director, MD, MPH, FRCPC, FCAHS

Jocelyn Cruickshank

Jocelyn Cruickshank

Board of Directors Chair

Shauneen Kellner

Shauneen Kellner

Executive Director

Follow Us on Social Media

Funders and Partners

Subscribe to

The Arthritis eNewsletter

...and recieve our quarterly eNewsletter and other notifications about the latest in arthritis research and more. 

You have Successfully Subscribed!